Current News

Contact | Print version | PDF version | Send article | RSS-Feed

Nanogen Announces Collaboration with Canadian Agencies to Develop Veterinary and Bioterror Diagnostics

15 Jun 2007 - Nanogen, Inc. announced that it has received project funding from several Canadian agencies, including the Canadian Food Inspection Agency (CFIA). The purpose of the funding and collaborative agreement is to develop diagnostic tools for the detection of natural or potential bioterror threats to livestock, such as foot and mouth disease and avian flu, employing the company's NanoChip(R) platform.
 
"Although the majority of our NanoChip(R) instruments are used in basic research and human clinical diagnostics applications, we have always known that the platform's flexibility confers benefit in other markets, such as veterinary diagnostics and the monitoring of bioterror threats," said Nanogen president and chief operating officer David Ludvigson.
 
The project, titled "Adaptation of Recently Developed DNA Microarrays to NanoChip Microarray Technology for Detection of Agroterrorism Agents" was approved by Defence Research and Development Canada through the CRTI Program (CBRNE (Chemical, Biological, Radiological, and Nuclear) Research and Technology Initiative (CRTI). Financial terms were not disclosed. Additional collaborators include the CFIA's laboratory in Lethbridge, Alberta and the National Center for Foreign Animal Diseases located in Winnipeg, Manitoba.